Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 72

1.

Carbon-ion radiotherapy combined with chemotherapy for head and neck mucosal melanoma: Prospective observational study.

Takayasu Y, Kubo N, Shino M, Nikkuni O, Ida S, Musha A, Takahashi K, Hirato J, Shirai K, Saitoh JI, Yokoo S, Chikamatsu K, Ohno T, Nakano T; Working Group on Head and Neck Tumors.

Cancer Med. 2019 Dec;8(17):7227-7235. doi: 10.1002/cam4.2614. Epub 2019 Oct 16.

2.

Prospective observational study of carbon-ion radiotherapy for non-squamous cell carcinoma of the head and neck.

Shirai K, Saitoh JI, Musha A, Abe T, Kobayashi D, Takahashi T, Tamaki T, Kawamura H, Takayasu Y, Shino M, Toyoda M, Takahashi K, Hirato J, Yokoo S, Chikamatsu K, Ohno T, Nakano T; Working Group on Head and Neck Tumors.

Cancer Sci. 2017 Oct;108(10):2039-2044. doi: 10.1111/cas.13325. Epub 2017 Aug 17.

3.

Concurrent chemoradiotherapy with conventional fractionated radiotherapy and low-dose daily cisplatin plus weekly docetaxel for T2N0 glottic cancer.

Saitoh JI, Shirai K, Imaeda M, Musha A, Abe T, Shino M, Takayasu Y, Takahashi K, Chikamatsu K, Nakano T.

Radiat Oncol. 2017 Feb 20;12(1):39. doi: 10.1186/s13014-016-0741-4.

4.

[Sequential Chemoradiotherapy for Advanced Head and Neck Cancer: A Clinical Study with 33 Cases].

Takahashi K, Nakajima K, Murata T, Shino M, Nikkuni O, Toyoda M, Takayasu Y, Chikamatsu K.

Nihon Jibiinkoka Gakkai Kaiho. 2016 May;119(5):734-40. Japanese.

PMID:
27459819
5.

Expression of ER stress markers (GRP78/BiP and PERK) in patients with tongue cancer.

Kaira K, Toyoda M, Shimizu A, Mori K, Shino M, Sakakura K, Takayasu Y, Takahashi K, Oyama T, Asao T, Chikamatsu K.

Neoplasma. 2016;63(4):588-94. doi: 10.4149/neo_2016_412.

PMID:
27268922
6.

[Development and perspective for the Biosimilar medicines].

Takayasu Y, Tsukamoto T.

Nihon Yakurigaku Zasshi. 2016 May;147(5):303-9. doi: 10.1254/fpj.147.303. Review. Japanese. No abstract available.

PMID:
27181727
7.

Synthesis of the (9R,13R)-isomer of LDS1, a flower-inducing oxylipin isolated from Lemna paucicostata.

Takayasu Y, Ogura Y, Towada R, Kuwahara S.

Biosci Biotechnol Biochem. 2016 Aug;80(8):1459-63. doi: 10.1080/09168451.2016.1166935. Epub 2016 Mar 29.

PMID:
27023212
8.

Oxygen-glucose deprivation increases firing of unipolar brush cells and enhances spontaneous EPSCs in Purkinje cells in the vestibulo-cerebellum.

Takayasu Y, Shino M, Nikkuni O, Yoshida Y, Furuya N, Chikamatsu K.

Neurosci Res. 2016 May;106:1-11. doi: 10.1016/j.neures.2015.10.009. Epub 2015 Nov 1.

PMID:
26535811
9.

Expression of ER stress markers (GRP78/BiP and PERK) in adenoid cystic carcinoma.

Kaira K, Toyoda M, Shimizu A, Shino M, Sakakura K, Takayasu Y, Takahashi K, Asao T, Chikamatsu K.

Acta Otolaryngol. 2016;136(1):1-7. doi: 10.3109/00016489.2015.1083120. Epub 2015 Sep 14.

PMID:
26366837
10.

[Prediction of Post-operative Lymph Node Metastasis with a Molecular Biological Test in Head and Neck Cancer].

Takahashi K, Nakajima K, Shino M, Toyoda M, Takayasu Y, Chikamatsu K.

Nihon Jibiinkoka Gakkai Kaiho. 2015 Feb;118(2):135-9. Japanese.

PMID:
26336794
11.

Estradiol pretreatment ameliorates impaired synaptic plasticity at synapses of insulted CA1 neurons after transient global ischemia.

Takeuchi K, Yang Y, Takayasu Y, Gertner M, Hwang JY, Aromolaran K, Bennett MV, Zukin RS.

Brain Res. 2015 Sep 24;1621:222-30. doi: 10.1016/j.brainres.2014.11.016. Epub 2014 Nov 22.

12.

CD98 as a novel prognostic indicator for patients with stage III/IV hypopharyngeal squamous cell carcinoma.

Toyoda M, Kaira K, Shino M, Sakakura K, Takahashi K, Takayasu Y, Tominaga H, Oriuchi N, Nikkuni O, Suzuki M, Iijima M, Tsukamoto N, Nagamori S, Kanai Y, Oyama T, Chikamatsu K.

Head Neck. 2015 Nov;37(11):1569-74. doi: 10.1002/hed.23797. Epub 2014 Aug 1.

PMID:
24913970
13.

Prognostic significance of amino-acid transporter expression (LAT1, ASCT2, and xCT) in surgically resected tongue cancer.

Toyoda M, Kaira K, Ohshima Y, Ishioka NS, Shino M, Sakakura K, Takayasu Y, Takahashi K, Tominaga H, Oriuchi N, Nagamori S, Kanai Y, Oyama T, Chikamatsu K.

Br J Cancer. 2014 May 13;110(10):2506-13. doi: 10.1038/bjc.2014.178. Epub 2014 Apr 24.

14.

Improvement of tracheal flap method for laryngotracheal separation.

Shino M, Yasuoka Y, Murata T, Ninomiya H, Takayasu Y, Takahashi K, Chikamatsu K.

Laryngoscope. 2013 Feb;123(2):440-5. doi: 10.1002/lary.23632. Epub 2012 Oct 15.

PMID:
23070689
15.

Caveolin-1 knockout mice exhibit impaired induction of mGluR-dependent long-term depression at CA3-CA1 synapses.

Takayasu Y, Takeuchi K, Kumari R, Bennett MV, Zukin RS, Francesconi A.

Proc Natl Acad Sci U S A. 2010 Dec 14;107(50):21778-83. doi: 10.1073/pnas.1015553107. Epub 2010 Nov 23.

16.

Dysregulation of mTOR signaling in fragile X syndrome.

Sharma A, Hoeffer CA, Takayasu Y, Miyawaki T, McBride SM, Klann E, Zukin RS.

J Neurosci. 2010 Jan 13;30(2):694-702. doi: 10.1523/JNEUROSCI.3696-09.2010.

17.

SNAP-25 is a target of protein kinase C phosphorylation critical to NMDA receptor trafficking.

Lau CG, Takayasu Y, Rodenas-Ruano A, Paternain AV, Lerma J, Bennett MV, Zukin RS.

J Neurosci. 2010 Jan 6;30(1):242-54. doi: 10.1523/JNEUROSCI.4933-08.2010.

18.

A single fear-inducing stimulus induces a transcription-dependent switch in synaptic AMPAR phenotype.

Liu Y, Formisano L, Savtchouk I, Takayasu Y, Szabó G, Zukin RS, Liu SJ.

Nat Neurosci. 2010 Feb;13(2):223-31. doi: 10.1038/nn.2474. Epub 2009 Dec 27.

19.

Regulation of NMDA receptor Ca2+ signalling and synaptic plasticity.

Lau CG, Takeuchi K, Rodenas-Ruano A, Takayasu Y, Murphy J, Bennett MV, Zukin RS.

Biochem Soc Trans. 2009 Dec;37(Pt 6):1369-74. doi: 10.1042/BST0371369.

20.

Functions of glutamate transporters in cerebellar Purkinje cell synapses.

Takayasu Y, Iino M, Takatsuru Y, Tanaka K, Ozawa S.

Acta Physiol (Oxf). 2009 Sep;197(1):1-12. doi: 10.1111/j.1748-1716.2009.02019.x. Epub 2009 Jul 6. Review.

PMID:
19583702
21.

Developmental switch in requirement for PKA RIIbeta in NMDA-receptor-dependent synaptic plasticity at Schaffer collateral to CA1 pyramidal cell synapses.

Yang Y, Takeuchi K, Rodenas-Ruano A, Takayasu Y, Bennett MV, Zukin RS.

Neuropharmacology. 2009 Jan;56(1):56-65. doi: 10.1016/j.neuropharm.2008.08.013. Epub 2008 Aug 22.

22.

Facilitated activation of metabotropic glutamate receptors in cerebellar Purkinje cells in glutamate transporter EAAT4-deficient mice.

Nikkuni O, Takayasu Y, Iino M, Tanaka K, Ozawa S.

Neurosci Res. 2007 Nov;59(3):296-303. Epub 2007 Jul 27.

PMID:
17727989
23.

Edaravone, a radical scavenger, inhibits mitochondrial permeability transition pore in rat brain.

Takayasu Y, Nakaki J, Kawasaki T, Koda K, Ago Y, Baba A, Matsuda T.

J Pharmacol Sci. 2007 Apr;103(4):434-7. Epub 2007 Apr 4.

24.

A novel pathway involving melanoma differentiation associated gene-7/interleukin-24 mediates nonsteroidal anti-inflammatory drug-induced apoptosis and growth arrest of cancer cells.

Zerbini LF, Czibere A, Wang Y, Correa RG, Otu H, Joseph M, Takayasu Y, Silver M, Gu X, Ruchusatsawat K, Li L, Sarkar D, Zhou JR, Fisher PB, Libermann TA.

Cancer Res. 2006 Dec 15;66(24):11922-31.

25.
26.

Successful video-assisted mediastinoscopic drainage of descending necrotizing mediastinitis.

Shimizu K, Otani Y, Nakano T, Takayasu Y, Yasuoka Y, Morishita Y.

Ann Thorac Surg. 2006 Jun;81(6):2279-81.

PMID:
16731169
27.

Roles of glial glutamate transporters in shaping EPSCs at the climbing fiber-Purkinje cell synapses.

Takatsuru Y, Takayasu Y, Iino M, Nikkuni O, Ueda Y, Tanaka K, Ozawa S.

Neurosci Res. 2006 Feb;54(2):140-8. Epub 2005 Dec 27.

PMID:
16377014
28.

Novel method for recording vestibular evoked myogenic potential: minimally invasive recording on neck extensor muscles.

Sakakura K, Takahashi K, Takayasu Y, Chikamatsu K, Furuya N.

Laryngoscope. 2005 Oct;115(10):1768-73.

PMID:
16222192
29.

Differential roles of glial and neuronal glutamate transporters in Purkinje cell synapses.

Takayasu Y, Iino M, Kakegawa W, Maeno H, Watase K, Wada K, Yanagihara D, Miyazaki T, Komine O, Watanabe M, Tanaka K, Ozawa S.

J Neurosci. 2005 Sep 21;25(38):8788-93.

30.

Effects of a novel glutamate transporter blocker, (2S, 3S)-3-[3-[4-(trifluoromethyl)benzoylamino]benzyloxy]aspartate (TFB-TBOA), on activities of hippocampal neurons.

Tsukada S, Iino M, Takayasu Y, Shimamoto K, Ozawa S.

Neuropharmacology. 2005 Mar;48(4):479-91. Epub 2005 Jan 25.

PMID:
15755476
31.

Roles of glutamate transporters in shaping excitatory synaptic currents in cerebellar Purkinje cells.

Takayasu Y, Iino M, Ozawa S.

Eur J Neurosci. 2004 Mar;19(5):1285-95.

PMID:
15016086
32.
33.

Oxidative modification of NK30424A and B enhance inhibitory effect on lipopolysaccharide-induced tumour necrosis factor-alpha promoter activity.

Takayasu Y, Tsuchiya K, Sukenaga Y.

J Antibiot (Tokyo). 2002 Mar;55(3):337-40. No abstract available.

34.

NK30424A and B, novel inhibitors of lipopolysaccharide-induced tumour necrosis factor alpha production, produced by Streptomyces sp. NA30424.

Takayasu Y, Tsuchiya K, Aoyama T, Sukenaga Y.

J Antibiot (Tokyo). 2001 Dec;54(12):1111-5. No abstract available.

35.

[Hepatic arterial infusion chemotherapy for hepatocellular carcinoma by EEP regimen].

Takayasu Y.

Nihon Rinsho. 2001 Oct;59 Suppl 6:624-8. Review. Japanese. No abstract available.

PMID:
11762024
36.

Glia-synapse interaction through Ca2+-permeable AMPA receptors in Bergmann glia.

Iino M, Goto K, Kakegawa W, Okado H, Sudo M, Ishiuchi S, Miwa A, Takayasu Y, Saito I, Tsuzuki K, Ozawa S.

Science. 2001 May 4;292(5518):926-9.

37.

[Radiation exposure to patient and radiologist during transcatheter arterial embolization for hepatocellular carcinoma].

Ishiguchi T, Nakamura H, Okazaki M, Sawada S, Takayasu Y, Hashimoto S, Hayashi N, Furui S, Koyama S, Maekoshi H.

Nihon Igaku Hoshasen Gakkai Zasshi. 2000 Dec;60(14):839-44. Japanese.

PMID:
11197834
38.

Phase I/II study of intravenous nedaplatin and intraarterial cisplatin with transcatheter arterial embolization for patients with locally advanced uterine cervical carcinoma.

Adachi S, Ogasawara T, Wakimoto E, Tsuji Y, Takemura T, Koyama K, Takayasu Y, Inoue J, Nakao N.

Cancer. 2001 Jan 1;91(1):74-9.

PMID:
11148562
39.

[Hepatic arterial infusion chemotherapy using totally implantable port system].

Takayasu Y, Yamamoto S, Ikeda J.

Gan To Kagaku Ryoho. 2000 Sep;27(10):1516-20. Japanese.

PMID:
11015995
40.

[Regional differences of in vivo proton MR spectroscopy in developing human brain].

Ando K, Ishikura R, Morikawa T, Tominaga S, Takayasu Y, Miura K, Nakao N, Minagawa K, Tanizawa T, Takemura Y, Ikeda J.

Nihon Igaku Hoshasen Gakkai Zasshi. 2000 Mar;60(4):199-204. Japanese.

PMID:
10774181
41.

[Evaluation of hepatic toxicity following high-dose 5-FU arterial infusion chemotherapy: analysis of 42 cases of colorectal liver metastases].

Yamano T, Takayasu Y, Nakao N, Kubota A.

Nihon Igaku Hoshasen Gakkai Zasshi. 2000 Mar;60(3):94-102. Japanese.

PMID:
10741116
42.
43.

[Clinical experiences of implantable vascular access device, "Vital Port" for arterial infusion chemotherapy].

Takayasu Y, Kumada T, Ito K.

Gan To Kagaku Ryoho. 1999 Aug;26(9):1283-8. Japanese.

PMID:
10478181
44.

Intrahepatic interleukin-2 with chemotherapy for unresectable liver metastases: a randomized multicenter trial.

Okuno K, Yasutomi M, Kon M, Hatakeyama K, Muto T, Kitajima M, Koyanagi Y, Hamano K, Ohta H, Aiba K, Arai Y, Sowa M, Kikkawa N, Takayasu Y, Isomoto H.

Hepatogastroenterology. 1999 Mar-Apr;46(26):1116-21.

PMID:
10370677
45.

[Evaluation by MR imaging of neoadjuvant intra-arterial infusion chemotherapy in uterine cervical cancer].

Yamano T, Takayasu Y, Inoue J, Narasaki K, Ando K, Nakao N, Adachi S, Takemura T, Kohyama K.

Gan To Kagaku Ryoho. 1998 Jul;25(9):1322-5. Japanese.

PMID:
9703818
46.

[Arterial infusion of SMANCS-Lipiodol for advanced hepatocellular carcinoma].

Miura K, Nakao N, Yoshimoto A, Yamano T, Inoue J, Takayasu Y.

Gan To Kagaku Ryoho. 1998 Feb;25 Suppl 1:51-5. Japanese.

PMID:
9512688
48.

Determination of the optimum dose level of lipiodol in transcatheter arterial embolization of primary hepatocellular carcinoma based on retrospective multivariate analysis.

Nakao N, Uchida H, Kamino K, Nishimura Y, Ohishi H, Takayasu Y, Miura K.

Cardiovasc Intervent Radiol. 1994 Mar-Apr;17(2):76-80.

PMID:
8013027
49.

Effectiveness of Lipiodol in transcatheter arterial embolization of hepatocellular carcinoma.

Nakao N, Uchida H, Kamino K, Nishimura Y, Ohishi H, Takayasu Y, Nakamura H, Kuroda C, Fujita M, Yoshioka H, et al.

Cancer Chemother Pharmacol. 1992;31 Suppl:S72-6.

PMID:
1333913
50.

Outcome of localized hepatocellular carcinoma treated with segmental arterioportal chemoembolization.

Nakamura H, Oi H, Hori S, Takayasu Y, Furui S, Sawada S, Kozuka T.

Cancer Chemother Pharmacol. 1992;31 Suppl:S69-71.

PMID:
1333911

Supplemental Content

Loading ...
Support Center